Literature DB >> 1446099

Can the Lombard effect be used to improve low voice intensity in Parkinson's disease?

S G Adams1, A E Lang.   

Abstract

Low voice intensity is a common problem in Parkinson's disease. It is typically resistant to drug therapy and often persists despite extensive behavioural speech and language therapy. Based on previous findings that masking noise will produce a consistent increase in voice intensity in most normal individuals, the effects of white masking noise, presented at a sound pressure level of 90 dB, was examined in 10 parkinsonian patients with low voice intensity. Results indicated that all Parkinson's disease patients showed a marked increase in their voice intensity. Given this finding, it is proposed that masking noise may be an effective treatment for reduced voice intensity in parkinsonian speakers, particularly with the future adaptation of portable voice-activated maskers, such as the Edinburgh Masker.

Entities:  

Mesh:

Year:  1992        PMID: 1446099     DOI: 10.3109/13682829209012034

Source DB:  PubMed          Journal:  Eur J Disord Commun        ISSN: 0963-7273


  10 in total

1.  Vocal responses to unanticipated perturbations in voice loudness feedback: an automatic mechanism for stabilizing voice amplitude.

Authors:  Jay J Bauer; Jay Mittal; Charles R Larson; Timothy C Hain
Journal:  J Acoust Soc Am       Date:  2006-04       Impact factor: 1.840

2.  The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.

Authors:  Kelly Richardson; Joan E Sussman; Elaine T Stathopoulos
Journal:  J Commun Disord       Date:  2014 Nov-Dec       Impact factor: 2.288

3.  Laryngeal Aerodynamics in Healthy Older Adults and Adults With Parkinson's Disease.

Authors:  Deborah Matheron; Elaine T Stathopoulos; Jessica E Huber; Joan E Sussman
Journal:  J Speech Lang Hear Res       Date:  2017-03-01       Impact factor: 2.297

4.  Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.

Authors:  Supraja Anand; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2015-08       Impact factor: 2.297

5.  The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.

Authors:  Jordan L Manes; Ellen Herschel; Katharine Aveni; Kris Tjaden; Todd Parrish; Tanya Simuni; Daniel M Corcos; Angela C Roberts
Journal:  J Commun Disord       Date:  2021-08-31       Impact factor: 2.288

6.  Increased vocal intensity due to the Lombard effect in speakers with Parkinson's disease: simultaneous laryngeal and respiratory strategies.

Authors:  Elaine T Stathopoulos; Jessica E Huber; Kelly Richardson; Jennifer Kamphaus; Devan DeCicco; Meghan Darling; Katrina Fulcher; Joan E Sussman
Journal:  J Commun Disord       Date:  2013-12-28       Impact factor: 2.288

7.  Vocal responses to perturbations in voice auditory feedback in individuals with Parkinson's disease.

Authors:  Hanjun Liu; Emily Q Wang; Leo Verhagen Metman; Charles R Larson
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

8.  Exploring the potential of virtual reality technology to investigate the health and well being benefits of group singing.

Authors:  H Daffern; D A Camlin; H Egermann; A J Gully; G Kearney; C Neale; J Rees-Jones
Journal:  Int J Perform Arts Digit Media       Date:  2018-12-27

9.  A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.

Authors:  C M Sackley; C Rick; P Au; M C Brady; G Beaton; C Burton; M Caulfield; S Dickson; F Dowling; M Hughes; N Ives; S Jowett; P Masterson-Algar; A Nicoll; S Patel; C H Smith; R Woolley; C E Clarke
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279

10.  Lombard's effect's implication in intensity, fundamental frequency and stability on the voice of individuals with Parkinson's disease.

Authors:  Araken Quedas; André de Campos Duprat; Gisele Gasparini
Journal:  Braz J Otorhinolaryngol       Date:  2007 Sep-Oct
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.